pAAV9.HR

AAV packaging plasmid expressing AAV2 Rep protein and AAV9.HR capsid protein

AAV9.HR is a variant (H527Y+R533S) of AAV9 capsid, which retains AAV9’s capability to traverse the blood-brain barrier, transduce neurons and has the advantage of mitigating potential off-target effects in peripheral tissues compared to AAV9.
These results demonstrate that the AAV9.HR capsid mutant is suitable for vector development to target CNS diseases.

Wang, D., et al., A Rationally Engineered Capsid Variant of AAV9 for Systemic CNS-Directed and Peripheral Tissue-Detargeted Gene Delivery in Neonates. Molecular Therapy – Methods & Clinical Development, 2018. 9: p. 234-246.

>pAAV9.HR 

MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEPVNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEPLGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPPAAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHLYKQISNSTSGGSSNDNAYFGYSTPWGYFDFNRFHCHFSPRDWQRLINNNWGFRPKRLNFKLFNIQVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVFMIPQYGYLTLNDGSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLSKTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALNGRNSLMNPGPAMASYKEGEDSFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATESYGQVATNHQSAQAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSPLMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNPEIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL.

  • If you are interested in our products, please click on the ‘Add to WishList’ button below;
  • Please send your wishlist for details to [email protected] to get in touch with us;

pAAV9.HR

Price range: $1,500.00 through $3,000.00

SKU: pAAV9.HR Category:

Description

 

Additional information

Scale

5mg, 10mg

Scroll to Top